DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?

MLA

Valencia, Inés, et al. “DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?” Frontiers in Pharmacology, vol. 11, Aug. 2020, p. 1161. EBSCOhost, https://doi.org/10.3389/fphar.2020.01161.

APA

Valencia, I., Peiró, C., Lorenzo, Ó., Sánchez-Ferrer, C. F., Eckel, J., & Romacho, T. (2020). DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications? Frontiers in Pharmacology, 11, 1161. https://doi.org/10.3389/fphar.2020.01161

Chicago

Valencia, Inés, Concepción Peiró, Óscar Lorenzo, Carlos F Sánchez-Ferrer, Jürgen Eckel, and Tania Romacho. 2020. “DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?” Frontiers in Pharmacology 11 (August): 1161. doi:10.3389/fphar.2020.01161.